Nasdaq Copenhagen

OTC Markets Group Welcomes Netcompany Group AS to OTCQX

Retrieved on: 
måndag, mars 25, 2024

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Netcompany Group AS (Nasdaq Copenhagen: NETC; OTCQX: NTCYF), an IT services company, has qualified to trade on the OTCQX® Best Market.

Key Points: 
  • NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Netcompany Group AS (Nasdaq Copenhagen: NETC; OTCQX: NTCYF), an IT services company, has qualified to trade on the OTCQX® Best Market.
  • Netcompany Group AS upgraded to OTCQX from the Pink® market.
  • Netcompany Group AS begins trading today on OTCQX under the symbol “NTCYF.” Netcompany Group is the first Danish company with a market cap over $1 billion to join OTCQX.
  • Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors.

Aquaporin publishes prospectus and initiates rights issue

Retrieved on: 
fredag, april 5, 2024

COPENHAGEN, Denmark, April 5, 2024 /PRNewswire/ -- Aquaporin A/S ("Aquaporin" or the "Company") (CSE: AQP) today announces that its board of directors (the "Board of Directors") has resolved to initiate a rights issue with pre-emptive subscription rights (the "Pre-emptive Rights") for the Company's existing shareholders allowing for subscription of up to 14,594,872 new shares with a nominal value of DKK 1 each (the "New Shares") at a subscription price of DKK 14 per New Share (the "Subscription Price") (the "Offering" or the "Rights Issue").

Key Points: 
  • : DK28315694
    COPENHAGEN, Denmark, April 5, 2024 /PRNewswire/ -- Aquaporin A/S ("Aquaporin" or the "Company") (CSE: AQP) today announces that its board of directors (the "Board of Directors") has resolved to initiate a rights issue with pre-emptive subscription rights (the "Pre-emptive Rights") for the Company's existing shareholders allowing for subscription of up to 14,594,872 new shares with a nominal value of DKK 1 each (the "New Shares") at a subscription price of DKK 14 per New Share (the "Subscription Price") (the "Offering" or the "Rights Issue").
  • A prospectus regarding the Offering (the "Prospectus") is, subject to certain restrictions, available at the Company's website: https://investors.aquaporin.com/investors/default.aspx .
  • Trades of Pre-emptive Rights executed during the Rights Trading Period will, however, not be affected.
  • Consequently, investors who have acquired Pre-emptive Rights will incur a loss corresponding to the purchase price of the Pre-emptive Rights and any transaction costs.

Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference

Retrieved on: 
fredag, mars 1, 2024

Copenhagen, Denmark, March 1, 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no.

Key Points: 
  • Copenhagen, Denmark, March 1, 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no.
  • 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that Adam Steensberg, Chief Executive Officer, will present at TD Cowen’s 44th Annual Health Care Conference in Boston on Monday, March 4 at 1:30 – 2:00 p.m.
  • ET (7:30 – 8:00 p.m. CET).
  • A webcast of the presentation will be available at https://wsw.com/webcast/cowen154/zeal.co/2411784 and accessible through the Events page in the Investor section of Zealand Pharma’s website at https://www.zealandpharma.com/events/ where a replay will also be archived following the presentation.

Asetek - Q4 2023: Liquid Cooling Demand and SimSports Expansion Driving Growth

Retrieved on: 
fredag, mars 8, 2024

The growth in both periods mainly reflects increased shipments of liquid cooling products.

Key Points: 
  • The growth in both periods mainly reflects increased shipments of liquid cooling products.
  • "2023 represented a material rebound for our Liquid Cooling business and expansion of the SimSports product program to wide acclaim from the sim racing community.
  • In the first quarter of 2024, ten new liquid cooling products and various new SimSports accessories are expected to begin shipping.
  • Larger customers have expressed increased demand for Liquid Cooling products with a lower price point for the Chinese market as well as other value-oriented markets.

Genmab Announces Initiation of Share Buy-Back Program

Retrieved on: 
onsdag, februari 14, 2024

The share buy-back program will be undertaken on the terms set out below and in accordance with Regulation (EU) No.

Key Points: 
  • The share buy-back program will be undertaken on the terms set out below and in accordance with Regulation (EU) No.
  • The share buy-back program will start on February 15, 2024, and end on March 15, 2024 (unless Genmab terminates or suspends the program).
  • Genmab has appointed Danske Bank as lead manager for the share buy-back program.
  • Upon initiation of the program, Genmab will issue a weekly announcement in respect of transactions made under the program.

Playmaker Capital Inc. Announces Closing of Acquisition by Better Collective

Retrieved on: 
tisdag, februari 6, 2024

Playmaker Capital Inc. (TSX-V: PMKR) (“Playmaker” or the “Company”), the digital sports media company that delivers authentic content experiences through its portfolio of sports media brands, is pleased to announce the closing of its previously announced plan of arrangement under the Business Corporations Act (Ontario) (the “Arrangement”) with Better Collective A/S (“Better Collective”).

Key Points: 
  • Playmaker Capital Inc. (TSX-V: PMKR) (“Playmaker” or the “Company”), the digital sports media company that delivers authentic content experiences through its portfolio of sports media brands, is pleased to announce the closing of its previously announced plan of arrangement under the Business Corporations Act (Ontario) (the “Arrangement”) with Better Collective A/S (“Better Collective”).
  • Jordan Gnat, Co-Founder and Chief Executive Officer of Playmaker, said “Today the Playmaker family begins the next phase of our journey by joining the Better Collective family.
  • A special thank you to Jesper, Christian and the Better Collective team for the confidence you have shown in our team.
  • Prior to closing of the Arrangement, Better Collective held no Common Shares.

Nordea cancels repurchased shares

Retrieved on: 
tisdag, januari 30, 2024

Nordea has today cancelled 6,779,548 treasury shares in line with the decision by the Board of Directors.

Key Points: 
  • Nordea has today cancelled 6,779,548 treasury shares in line with the decision by the Board of Directors.
  • The cancellation brings the total number of shares in Nordea to 3,521,499,960.
  • The cancellation of the shares was registered with the Finnish Trade Register on 18 January 2024.
  • The company holds 3,103,145 treasury shares for capital optimisation purposes and 4,787,315 treasury shares for remuneration purposes.

Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC

Retrieved on: 
onsdag, januari 10, 2024

Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC

Key Points: 
  • Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC
    Copenhagen, Denmark, 10 January 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no.
  • 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the receipt on 9 January 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from Avoro Capital Advisors LLC.
  • 1 / 2024, Avoro Life Sciences Fund LLC now holds nominally 3,438,184 shares in Zealand Pharma A/S, corresponding to 5.50% of the total share capital in Zealand Pharma A/S.
  • Avoro Capital Advisors LLC holds the corresponding number of voting rights to the shares.

Asetek A/S - Oslo Børs Approves Delisting of Asetek's Shares From Oslo Børs

Retrieved on: 
onsdag, december 20, 2023

AALBORG, Denmark, Dec. 20, 2023 /PRNewswire/ -- As resolved at the EGM of Asetek A/S ("Asetek") held on 5 December 2023, Asetek requested Oslo Børs to delist its shares from trading and official listing on Oslo Børs on 6 December 2023.

Key Points: 
  • AALBORG, Denmark, Dec. 20, 2023 /PRNewswire/ -- As resolved at the EGM of Asetek A/S ("Asetek") held on 5 December 2023, Asetek requested Oslo Børs to delist its shares from trading and official listing on Oslo Børs on 6 December 2023.
  • Oslo Børs has today approved the application to delist its shares from Oslo Børs.
  • Following the approval from Oslo Børs, the updated timeline contemplated by Asetek is as follows:
    6 December 2023: Delisting application submitted by Asetek.
  • Asetek's shares have been dual listed on Oslo Børs and Nasdaq Copenhagen, since the listing on Nasdaq Copenhagen on 17 May 2023 and will continue to be listed on Nasdaq Copenhagen following the delisting from Oslo Børs.

Asetek A/S - Publication of Request to Delist Asetek's Shares From Oslo Børs

Retrieved on: 
torsdag, december 7, 2023

AALBORG, Denmark, Dec. 6, 2023 /PRNewswire/ -- In continuation of Asetek A/S' ("Asetek") announcement on 8 March 2023 regarding Asetek's intention to list its shares on Nasdaq Copenhagen and subsequently apply for delisting of its shares on Oslo Børs, an extraordinary general meeting held on 5 December 2023 has resolved to approve an application for delisting of Asetek's shares on Oslo Børs.

Key Points: 
  • AALBORG, Denmark, Dec. 6, 2023 /PRNewswire/ -- In continuation of Asetek A/S' ("Asetek") announcement on 8 March 2023 regarding Asetek's intention to list its shares on Nasdaq Copenhagen and subsequently apply for delisting of its shares on Oslo Børs, an extraordinary general meeting held on 5 December 2023 has resolved to approve an application for delisting of Asetek's shares on Oslo Børs.
  • As such, Asetek has today submitted an application for delisting of Asetek's shares to Oslo Børs.
  • Provided that Oslo Børs accepts the application, and subject to any further requirements from Oslo Børs, the delisting is expected to be completed on or about 1 April 2024.
  • Asetek's shares have been dual listed on Oslo Børs and Nasdaq Copenhagen, since the listing on Nasdaq Copenhagen on 17 May 2023 and will continue to be listed on Nasdaq Copenhagen following the delisting from Oslo Børs.